MetaCap

InMed Pharmaceuticals (INM) vs Redhill Biopharma (RDHL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

InMed Pharmaceuticals is the larger company by market cap ($7.3 million vs $5.1 million), about 1.4 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

INM0.00%RDHL+21.94%
+23%+11%-1%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

INM versus RDHL key metrics
MetricINMRDHL
Share price$1.33$0.578
Market cap$7.31M$5.14M
1-day change0.00%+21.94%
Forward P/E—19.27
EPS (TTM)$-2.84$0.00
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$2.40$2.14
52-week low$0.575$0.435
Distance from 52-week high-44.58%-72.99%
Average volume914.23K2.05M
Shares outstanding5.49M8.89M
Employees613
SectorHealthcareHealthcare
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & Generic

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About InMed Pharmaceuticals

INM stock →

InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States.

Healthcare · Drug Manufacturers - Specialty & Generic · 6 employees

About Redhill Biopharma

RDHL stock →

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H.

Healthcare · Drug Manufacturers - Specialty & Generic · 13 employees

INM vs RDHL FAQ

Which is bigger, InMed Pharmaceuticals or Redhill Biopharma?

InMed Pharmaceuticals (INM) is larger, with a market capitalization of $7.31M compared with $5.14M for Redhill Biopharma (RDHL).

Are InMed Pharmaceuticals and Redhill Biopharma in the same industry?

Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

More comparisons